详情页 - 首都医科大学宣武医院知识库

当前位置：首页 > 详情页

A Real-world Study to Evaluate the Primary Patency and Freedom From TLR of Endovascular Treatment in TOSAKA III In-stent Restenosis of Lower Extremity Femoropopliteal Artery. (FP-Restore)

77| 认领 | 链接全文 |

文献详情

编号/登记号：

注册时间：

研究开始时间：

研究结束时间：

项目类型：

本院角色：

多中心研究：

招募状态：

研究疾病/适应症：

研究类型：

研究负责人：

研究单位： [1]Shanghai Zhongshan Hospital [2]RenJi Hospital [3]First Affiliated Hospital of Zhejiang University [4]Chengdu University of Traditional Chinese Medicine [5]Xuanwu Hospital, Beijing [6]First People's Hospital of Hangzhou [7]Qingdao Hiser Medical Group [8]Second Affiliated Hospital of Soochow University [9]Liyuan Hospital of Tongji Medical College of Huazhong University of Science and Technology

关键词： in-stent restenosis

研究目的：

This study is a prospective, multi-center, real world, observational study, which aims at evaluating the safety, efficacy and economic cost of endovascular treatments for endovascular therapies in tosaka III (totally occluded) in-stent restenosis.It is estimated that 300 subjects diagnosed with tosaka III in-stent restenosis and receive endovascular treatments will be enrolled in nine centers from April 2021 to December 2022 nation-widely. All the subjects will be under follow-up for 24 months. There is no restriction on the endovascular techniques. The primary outcomes include clinical-driven freedom from TLR at 24 months.